Assertio Holdings, Inc. (ASRT)
11.47
+0.34
(+3.05%)
USD |
NASDAQ |
Jan 16, 16:00
11.56
+0.09
(+0.78%)
After-Hours: 20:00
Assertio Holdings SG&A Expense (TTM): 63.52M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Perspective Therapeutics, Inc. | 31.53M |
| Altimmune, Inc. | 22.68M |
| Actinium Pharmaceuticals, Inc. | 15.79M |
| Aldeyra Therapeutics, Inc. | 9.186M |
| Myomo, Inc. | 32.71M |